Vertebrate Bitter Taste Receptors: Keys for Survival ... - ACS Publications

Perspective pubs.acs.org/JAFC

Vertebrate Bitter Taste Receptors: Keys for Survival in Changing Environments Maik Behrens* and Wolfgang Meyerhof Department of Molecular Genetics, German Institute of Human Nutrition Potsdam-Rehbruecke, Arthur-Scheunert-Allee 114-116, 14558 Nuthetal, Germany ABSTRACT: Research on bitter taste receptors has made enormous progress during recent years. Although in the early period after the discovery of this highly interesting receptor family special emphasis was placed on the deorphanization of mainly human bitter taste receptors, the research focus has shifted to sophisticated structure−function analyses, the discovery of small-molecule interactors, and the pharmacological profiling of nonhuman bitter taste receptors. These findings allowed novel perspectives on, for example, evolutionary and ecological questions that have arisen and that are discussed. KEYWORDS: bitter taste perception, G protein-coupled receptors

■

INTRODUCTION The ability of vertebrates to sense bitterness is thought to be important for the avoidance of potentially toxic compounds occurring frequently in nature, although a clear correlation between bitterness and toxicity is lacking.1 The detection of these substances is mediated by G protein-coupled receptors belonging to the taste 2 receptor (TAS2R) family that are present in specialized taste receptor cells located on the tongue and in the oral cavity. Following their discovery in 2000,2−4 enormous progress has been made including the functional characterization, establishment of intra- and extraoral expression patterns, determination of structure−function relationships, and other biochemical as well as cell biological details. More recently, the identification of bitter taste receptor repertoires of a larger collection of vertebrates and the acquisition of the agonist profiles detected by some of these receptors allowed better insights in the evolutionary processes shaping these highly interesting proteins. However, the answers to many of the early questions resulted in new, so far unanswered, questions, which need to be addressed in the future. Rather than reviewing all aspects of bitter taste research, the present paper will highlight only some of the past developments and achievements in the field and how they shaped current views and, likely, future research directions.

narrow range of substances detected by these proteins, raising the obvious question of how can so few receptors facilitate the detection of almost countless and chemically diverse bitter agonists? A reasonable solution to this problem came from the observation that human TAS2Rs are able to form homo- and heterodimers with each other in vitro and, because the possible combinations appeared unrestricted, 325 homo- and heterodimeric receptors could exist.6 However, it is still unknown if bitter taste receptor heterodimers contribute to a broadening of the detectable agonist spectrum as it was not possible to identify functional consequences of the oligomerization despite considerable efforts.6 To date, all reported bitter taste receptor responses in vitro can be ascribed to monomeric or homodimeric receptors. The discovery of the much broader tuning properties of the human TAS2R14, which responded to about a fourth of the tested compounds,7 hinted at another possible solution for the apparent discrepancy between receptor number and the plethora of bitter tastants, as some receptors may contribute to the overall bitter taste profile of humans more than others. Indeed, after the deorphanization of 21 of the ∼25 putative functional human bitter taste receptors,8,9 it appears that the number of TAS2Rs is fully sufficient to facilitate the detection of that many bitter substances. In general, the human TAS2Rs can be categorized into four groups, the three receptor “generalists” with extensive agonist spectra comprising TAS2R10, TAS2R14, and TAS2R46, each able to respond to about one-third of the bitter substances (their combined activities suffice for the detection of about half of the bitter substances tested so far), a number of narrowly tuned receptor “specialists” that detect few bitter compounds, and the intermediately tuned receptors representing the majority, as well as two receptors, TAS2R16 5 and

■

BITTER TASTE RECEPTORS Human Bitter Taste Receptor Repertoire. The enormous variety of bitter substances is detected by G proteincoupled receptors of the taste 2 receptor (gene symbol = TAS2R (human), Tas2r (mouse)) family. The first functionally characterized receptors, mouse Tas2r105 (mT2R5), mouse Tas2r108 (mT2R8), and human TAS2R4 (hT2R4), were shown to respond to 1 or maximally 2 of 55 diverse bitter compounds used for functional screening, suggesting that bitter taste receptor genes could be specialized for the detection of distinct agonists.3 Although the subsequently deorphaned human TAS2R16 was demonstrated to respond to numerous chemically closely related β-D-glucopyranosides,5 the pronounced specificity of this receptor again pointed toward a © 2016 American Chemical Society

Special Issue: 11th Wartburg Symposium on Flavor Chemistry and Biology Received: Revised: Accepted: Published: 2204

October 28, 2016 December 19, 2016 December 25, 2016 December 25, 2016 DOI: 10.1021/acs.jafc.6b04835 J. Agric. Food Chem. 2018, 66, 2204−2213

Perspective

Journal of Agricultural and Food Chemistry

receptor responds to various cyanogenic β-D-glucopyranosides such as amygdalin from bitter almonds and linamarin from manioc, it was suggested that the low-sensitive variant dominates in regions with an elevated malaria risk, because a lower sensitivity for bitter vegetables containing cyanogenic-βD-glucopyranosides in humans could exert antimalarial activity, causing protective sickle cell-like symptoms.19 A recent study, however, challenged the regional correlation between the occurrence of low-sensitive TAS2R16 alleles and malaria risk.22 Among the mentioned functional polymorphisms, two have been associated with nongustatory TAS2R functions. Whereas the nonfunctional TAS2R9V187 is associated with an elevated diabetes mellitus risk, which could be attributable to its expression in enteroendocrine L-cells secreting blood glucose regulating incretin hormones,13 the nonfunctional TAS2R38A49V262I296, the expression of which in human sinonasal epithelia was detected, correlated with an increased frequency of upper-airway infections.21,23 As more and more studies on extraoral expression of TAS2Rs emerge, it appears likely that TAS2R polymorphisms have profound physiological consequences apart from perceptual differences. Structure−Function Analyses. The thorough characterization of human TAS2Rs, on the one hand, raised questions about the architecture of the binding pockets that enable these receptors to accommodate so many diverse bitter substances, yet maintain an astonishing degree of specificity, and, on the other hand, provided the basis for careful structure−function analyses. Consequently, in the recent years several studies have been devoted to elucidating structural features of TAS2Rs involved in agonist activation. As these studies were the subject of detailed reviews,24−26 only some facets of the findings shall be presented here. Already the first detailed structure−function study devoted to one of the broadly tuned human bitter taste receptors, TAS2R46, found an answer to the question of whether large ligand profiles may require the existence of multiple binding pockets rather than relying on a single binding site. By a combination of functional calcium-mobilization assays and extensive site-directed mutagenesis as well as in silico homology modeling and ligand docking experiments, it was shown that agonists interact with the receptor in a single orthosteric binding pocket with overlapping, but individual, contact points.27 Recently, a subsequent study found evidence that agonists before entering the orthosteric binding pocket transiently occupy a vestibular binding site, which may act as a “specificity filter” for agonists.28 In light of the complex and concentrated mixtures of chemicals to which TAS2Rs are exposed during eating, this seems to represent an appealing mechanism to enhance detection accuracy. In another study investigating the likewise broadly tuned human TAS2R10, two intriguing observations were presented. 29 First, it was demonstrated that several amino acid residues located in the binding pocket of this receptor were highly agonist selective, supporting the interaction with some agonists while perturbing optimal interaction with other agonists, suggesting that this receptor is optimized to interact with many agonists at the expense of potentially higher affinities for individual agonists (Figure 2). Second, the finding that the binding mode for the toxic alkaloid strychnine in TAS2R10 differs from that of the same molecule in TAS2R46 indicates that the ability of different TAS2Rs to respond to the same bitter substances is not necessarily the result of conserved pharmacological features “inherited” from common ancestral bitter receptors, but rather evolved independently during evolution. Moreover, the above-

TAS2R38,10 which exhibit pronounced selectivity for defined classes of chemicals (Figure 1).

Figure 1. Contribution of differently tuned bitter taste receptors to overall bitter perception. More than 100 bitter substances were screened for their activation of 25 human TAS2Rs. The fractions of substances detected by receptors with broad, intermediate, narrow, and chemical group-specific (group spec.) detection spectra are indicated. The human TAS2Rs belonging to the four groups are indicated.

TAS2R Gene Variants. Shortly after the discovery of human TAS2R genes, it was recognized that numerous genetic polymorphisms of these genes exist with high frequencies in the human population.11,12 Some of the TAS2R variants resulting from these polymorphisms were subsequently shown to affect the function of the corresponding receptors contributing to individual bitter taste perception. Whereas some of the genetic variations result in the complete loss of receptor function due to incapacitating changes of the receptors’ polypeptide chains10,13,14 or the genomic deletion of entire TAS2R genes,15−18 other variants exhibit more subtle changes leading to reduced receptor responsiveness.19 The best investigated genetic polymorphism in a TAS2R gene affects the receptor TAS2R38.12 The two major alleles occur with rather similar frequencies in most populations and determine the ability to taste the synthetic bitter substances phenylthiocarbamide (PTC) and 6-n-propylthiouracil (PROP). The functional taster variant exhibits three amino acid sequence differences at positions 49, 262, and 296 compared to the nonfunctional nontaster variant.14 Whereas the taster variant TAS2R38P49A262V296 confers exquisite sensitivity for PTC and PROP, TAS2R38A49V262I296 shows no response in vitro.10 Also, natural compounds activating human TAS2R38 are plentiful and may thus influence food choice20 and innate immunity, because TAS2R38 has been reported to respond to bacterial quorum sensing molecules and is implicated in pathogen defense reactions.21 Other variations resulting in nonfunctional bitter taste receptors affect TAS2R9 (missense mutation), 13 TAS2R46 (nonsense mutation),11,16 and TAS2R43 and TAS2R45 (whole gene deletions).15−18 Additional TAS2R variants affect the receptors TAS2R16,19 TAS2R31 (former gene symbol TAS2R44), and TAS2R43;15,17 however, these receptors do not lose their function completely. A highly interesting case is presented by receptor TAS2R16, which occurs as a low-sensitive variant with high frequency in some areas of the African continent, whereas outside Africa exclusively the high-sensitive variant is found.19 Because this 2205

DOI: 10.1021/acs.jafc.6b04835 J. Agric. Food Chem. 2018, 66, 2204−2213

Perspective


indicated by both substantial sequence variation among Tas2r paralogues and considerable differences in the sizes of Tas2r gene repertoires among vertebrates, which range from 0−1 putatively functional genes in penguins35 and cetaceans (including, e.g., whales)36−40 over ∼25 in humans41 to almost 80 in the coelacanth.42 Not surprisingly, the number of pseudogenes is also subject to intense variation. Some hypotheses that could explain the considerable variability of the numbers of potentially intact bitter receptors have been formulated and may help to explain why humans fit between the extremes, although throughout human history dietary habits, including the acceptance of bitter food items, were clearly influenced by changing sociocultural factors as well (for reviews, see refs 43 and 44). One such hypothesis is that a low number of intact bitter taste receptor genes indicates inferior bitter-tasting abilities or even the complete loss of the sense of taste. Indeed, some animals that swallow their prey whole such as dolphins and other cetaceans have lost all or almost all of their taste receptors. Similarly, it has been speculated that chickens, which do not possess a functional sweet receptor and carry only three intact bitter taste receptor genes in the genome, have inferior tasting abilities (for a review, see ref 45). Several recent studies addressed the relationship between the numbers of bitter taste receptor genes in a broader set of vertebrates with the corresponding dietary habits.37,39,46,47 In general, it seems that herbivores, who more frequently encounter bitter substances than carnivores, possess more Tas2r genes. Whereas some studies found a positive correlation between diet and Tas2r gene numbers,37,39,46 other studies failed to obtain significant differences.47 Several reasons may exist for a somewhat skewed relationship between dietary habits and the number of bitter taste receptors. First, at least in some herbivore species the tolerance for the consumption of bitter plant constituents may result from improved degradation mechanisms that have co-evolved.48 Second, there is not a strict correlation between bitterness and toxicity,1 and therefore some variability in the receptor numbers may not immediately affect the chances for survival of species, in particular in highly specific habitats. Third, some bitter substances have even beneficial health effects, for example, in cases of infections with worms or other pathogens, which would suggest a role of Tas2rs in active seeking behavior for medicinal plants,49,50 and therefore a selective benefit beyond nutritional needs appears likely. Fourth, and related to the last point, it is still a matter of debate whether the vertebrates’ bitter-sensing system has some discriminative capacity (cf. ref 51 and references therein) and, thus, some bitter substances could be tolerated, whereas others lead to rejection behavior. If discrimination among bitter substances is possible and, in turn, connected with specialized Tas2rs for, for example, rejection, the simple counting of functional Tas2rs would insufficiently describe dietary preferences. Fifth, and perhaps most importantly, bitter taste receptor expression is not restricted to the oral cavity; an ever growing number of nongustatory tissues have been reported, indicating roles beyond taste (for recent reviews, see refs 23, 52, and 53). Although some of the expression sites such as the gastrointestinal tract may indicate an interaction with food-derived xenobiotics analogous to the role of Tas2rs in the oral cavity, their expression in other tissues such as respiratory tract (for a recent review, see ref 23), brain,54−57 mast cells,58 and white blood cells,59−62 testis (for a recent review, see ref 63), or heart,64,65 to name just a few, are difficult to correlate at present with dietary habits.

Figure 2. Binding pocket of human TAS2R10. Residues demonstrated to be critical for agonist activation in the binding pocket of the human bitter taste receptor TAS2R10 are shown. Three residues with pronounced agonist selectivity are depicted as bold stick representations. Other residues contributing to general agonist activation are indicated as think sticks. The center sphere indicates that sufficient space to accommodate large agonists is available in the binding pocket.

mentioned studies agree with structure−function analyses of other TAS2Rs such as the chemical class-specific TAS2R1630 and TAS2R3831 with respect to the location of the orthosteric binding pocket rather deeply buried in the upper one-third of the transmembrane domain area (Figure 3), although the

Figure 3. Schematic of a TAS2R embedded in the plasma membrane with bound agonist. The seven transmembrane domains connected by three extracellular and three intracellular loops of a TAS2R are indicated by cylinders and connecting lines. The amino terminus points to the extracellular site, and the carboxy terminus (not shown) is located at the intracellular site. The approximate ligand binding site in the upper third of the transmembrane domain helices is indicated by a strychnine molecule (red).

involved transmembrane domains may slightly differ among these TAS2Rs. Other papers suggested a more pronounced involvement of extracellular loops in ligand binding of TAS2R4,32 TAS2R31, and TAS2R43,33 and it remains to be seen whether these residues indeed contribute to the formation of the orthosteric binding site or rather indicate the general presence of vestibular sites in TAS2Rs. Comparing the location of binding sites of TAS2Rs with those of class A GPCRs, it must be stressed that similarities prevail25 and, hence, despite low overall sequence homology of TAS2Rs with other GPCRs, the structures and functional principles of TAS2Rs are far less exotic than initially thought. Tas2r Repertoires of Other Vertebrates. From an evolutionary perspective, the bitter taste receptor gene family represents a rather recent addition to the GPCR superfamily traceable back to teleostean fish (bony fish), but absent in cartilaginous fish such as elephant sharks.34 Even though the history of bitter taste receptor genes is not as long as those for many other GPCRs, their evolution has been more dynamic, leading to rapid diversification of the Tas2r genes. This is 2206


Perspective


Figure 4. Bitter taste receptor gene repertoires and tuning breadths. Bitter taste receptor repertoires of seven species that have been functionally characterized are shown. Putatively functional receptors are indicated by black squares and the adjacent number. Tuning widths of the receptors are indicated by the sizes of the spheres, and the fraction of test compounds that activated the corresponding receptor is provided in percent. Receptor symbols are given. Information for turkey, chicken, zebra finch, and Western clawed frog was derived from ref 66, information for cat was derived from ref 67, mouse data were taken from ref 69, and information for human was compiled from refs 8 and 69.

intact genes, similar characteristics possessing broadly tuned as well as intermediate and narrowly tuned receptors.67 The analyses of mouse Tas2rs revealed more interesting details. On the one hand, it was demonstrated that among the 35 putatively functional receptors, only a single receptor can be considered broadly tuned, whereas more narrowly tuned receptors exist. On the other hand, and most surprisingly, it was reported that orthologous receptors are not functionally conserved.69 In fact, for none of the compared mouse and human orthologues could an unambiguous functional conservation be demonstrated, indicating that even receptor pairs whose sequence was well conserved after the split of rodent and primate lineages contribute to diversification of bitter recognition rather than the detection of common agonists.69 An interesting possibility to investigate the evolutionary development of bitter taste receptor genes results from the availability of functional data on a large number of Tas2rs and detailed structure−function analyses on selected reference receptors. Combining such data, Lossow and colleagues69 were able to conclude that species-specific Tas2r gene expansions generated diversified receptor arrays by permutation of a few critical positions located in the ligand binding pockets of the Tas2r. This represents a highly efficient way to generate different agonist selectivities with a limited number of mutations. Moreover, such comparative data can be used to

Some of the above speculations were nourished by the fact that knowledge about the functions of bitter taste receptors was strongly human biased because no comprehensive analyses of other vertebrate Tas2r was performed until recently. The functional characterization of a number of nonhuman Tas2rs shed some light on the functional relationships among Tas2rs of different clades. Whereas previous studies concentrated on the characterization of a single or few Tas2rs from other species such as rodents, fish, and primates, recently more comprehensive analyses were published on avian, amphibian,66 carnivores,67,68 and mouse (Figure 4).69 An important outcome of the characterization of chicken and turkey Tas2rs was that very small bitter taste receptor repertoires represented by the three chicken and two turkey receptors do not necessarily indicate inferior bitter-tasting abilities.66 It was shown that the Tas2rs of chicken and turkey are on average very broadly tuned and, therefore, their low number is at least partially compensated by tuning breadth. On the other hand, a large number of Tas2rs, as in the cases of mice and the Western clawed-frog Xenopus tropicalis, apparently allows the development of highly specialized receptors.66,69 The Tas2r repertoire of the domestic cat (Felis catus) is until now the only functionally characterized bitter taste receptor repertoire within the order of carnivores67,68 and exhibits, albeit a relatively small Tas2r gene number with 12 potentially 2207


Perspective


structures today relies exclusively on homology modeling with template structures that derive from GPCRs with low amino acid homology. Hence, the corresponding models cannot be considered to represent high-resolution structures. Such structures would greatly improve the prediction of novel agonists but also help to design selective antagonists, which are urgently needed for basic research as well as for use in pediatric medicinal formulations. Therefore, attempts to obtain experimental structures for at least some of the TAS2Rs would significantly accelerate research in this area. Another rather poorly understood process concerns the ligand-induced conformational changes occurring during receptor activation. To date, just a single study has been devoted to investigate the mechanism of bitter taste receptor activation at the example of human TAS2R1.77 It would be important to intensify research devoted to the activation mechanism of TAS2Rs as the gained knowledge could aid the rational design of small-molecule modulators. Only recently was the relationship between the level of TAS2R38 mRNA in taste cells and human bitter perception established.78 As the expression strength of genes could be modulated by epigenetic mechanisms and food items have been associated with epigenetic modifications (for a review, see ref 79), it seems warranted to devote research efforts to study this interesting field, especially because TAS2R gene expression is not limited to the oral cavity. Bitter taste receptors can no longer be seen solely as taste receptors, because their expression and functional roles in other tissues such as the respiratory epithelia, gastrointestinal tract, testis, brain, and heart make them prime targets for drug design. Clarification of the roles that bitter taste receptors play outside the gustatory system is of outmost importance for many open and urgent questions. Whereas some of the activities exerted by the activation of bitter taste receptors in epithelia such as the gastrointestinal tract or airways might be related to xenobiotic detection as well, other tissues such as brain or heart are not directly accessible by bitter compounds from the outside environment. Here, the detection of yet unknown endogenously formed ligands might be conceivable. It would be a high priority to identify such endogenous ligands for bitter taste receptors and to elucidate the function of this detection system. Moreover, studies aiming at the evolutionary sequence of tissues acquiring bitter compound responsiveness would not only allow the identification of the original function of bitter taste receptors in vertebrates but also shed light on the interdependence of food resources and the evolutionary development of bitter taste receptor pharmacology.53 Of course, if bitter taste receptors have dominant functions aside from taste, the existence of a gene sharing-like mechanism like that proposed for lens crystalline genes80 would greatly affect the evolutionary flexibility of the Tas2r gene family.

trace changes in receptor specificities over a range of species with a limited number of functional data. Bitter Taste Receptor Gene Expression. In the mammalian oral cavity Tas2r genes are expressed in a specific subpopulation of type II taste receptor cells (TRCs), which do not overlap with those TRCs that express sweet or umami taste receptors.70 It has been a matter of debate whether the bitter TRCs represent uniform sensors for bitter substances expressing all Tas2r genes in every cell or whether they form a heterogeneous population where each bitter TRC expresses only subsets of them. On the one hand, in situ hybridization data with Tas2r probe mixtures2 as well as sophisticated functional complementation experiments in genetically modified mouse models71 were interpreted in support of a uniform bitter TRC population in rodents; on the other hand, independent in situ hybridization experiments using multiple probes4 and elaborate in vivo stimulation protocols on lingual slices of rats72 pointed to a heterogeneous bitter TRC population. Comprehensive analyses of Tas2r mRNAs in lingual tissues of humans51 and mice69 supported the existence of a heterogeneous bitter TRC population. Because a nonhomogeneous bitter TRC population would be a prerequisite for a possible discrimination among different bitter compounds, these findings have important implications. Although a number of studies investigated the bitter discriminatory capacity of mammals, a final answer to this question is still lacking as contrasting results were obtained (cf. ref 51 and references therein). Whereas it was demonstrated that indeed all Tas2r genes are expressed in gustatory tissues of the oral cavity of humans and mice51,69 and, hence, support a function as taste receptors, more specialized expression profiles seem to exist in extraoral tissues. Whereas 7 of the 35 putative functional mouse Tas2rs and about half of the 25 human TAS2Rs are expressed in cardiac tissue,65 the occurrence of these receptors in respiratory and gastrointestinal epithelia seems to be more heterogeneous as evident by the differential responses seen upon stimulation with different bitter compounds in rodent experiments.23,73 As some indications for nutrient-dependent regulation of Tas2r gene expression in gastrointestinal tissues have accumulated,65,74,75 these expression profiles may exhibit dynamic changes. It has to be mentioned that only a few studies provided direct evidence on the cell type(s) expressing Tas2rs in gastrointestinal tissues74−76 and, hence, the heterogeneity of bitter responsive cells could be even higher than assumed. The intriguing observation that Tas2r genes expressed in cardiac tissue are clustered together on the corresponding chromosomes65 suggests that common regulatory elements in these loci exist orchestrating tissue-specific expression. However, the frequent lack of identified cell types and the substantial overlap in agonist profiles identified for the individual Tas2rs currently does not allow conclusions about the biological meaning of the specific arrays of receptors found in nongustatory tissues. Future Directions. Despite the incredible gain in knowledge about bitter taste receptors over the past 16 years, open questions remain or have emerged in the course of the research. Although the architecture of the binding pockets of the broadly tuned TAS2Rs is quite well understood, it is not clear how a narrow tuning breadth is achieved. Hence, structure−function experiments on narrowly tuned TAS2Rs and subsequent comparison with TAS2Rs possessing large agonist panels are important to understand which mechanism(s) govern limited agonist spectra. The prediction of bitter taste receptor

■

BITTER COMPOUNDS Bitter substances occur plentifully in nature and cover a wide variety of chemicals that can differ in size, polarity, and chemical structures (cf. ref 81 and references therein). Whereas many bitter substances represent plant, fungal, or animal metabolites, other rich sources of bitter compounds are chemical processes occurring during cooking, fermentation, or chemical syntheses (Figure 5). At present, it is impossible to judge how many bitter compounds may exist in nature. Current data including synthetic compounds document over 680 bitter substances based on published functional receptor screenings 2208


Perspective


selectivity of the corresponding bitter receptors. Also, the bitter substance (−)-α-thujone, the psychotropic component of the liqueur absinthe, exerts its incapacitating effect via the inhibition of GABAA and 5-HT receptors.94 Glycin, GABAA, and 5-HT receptors are members of the neurotransmitter-gated ion channels of the Cys-loop receptor family (for a review, see ref 95) and, hence, unrelated to Tas2rs belonging to the GPCR family. Therefore, the protective interaction of these substances with Tas2rs evolved independently. Other bitter substances possess rather beneficial effects as they act as antimalarial agents in the case of artemisinin96 or can be used as analgesic, antiinflammatory, and antipyretic drugs such as D-(−)-salicin from willow bark.97 As different as the pharmacological activities are, the chemical classes of bitter compounds span a wide spectrum including amino acids and peptides, amines and amides, esters and lactones, ketones, fatty acids, phenols, alkaloids, metal ions, N-heterocyclic compounds, crown ethers, and azacycloalkanes as well as urea and related substances (for a more detailed list, see ref 81 and references therein). Somewhat surprisingly, naturally occurring bitter substances do not appear to activate the receptors better than synthetic compounds, despite their presumed coevolution. Among the compounds that taste most bitter to humans, we find the plant metabolite amarogentin as well as the synthetic substance denatonium benzoate, indicating that maximal bitterness may not be a particularly strong natural selector for human receptorsubstance co-evolution. Because the number of potent natural bitter compounds, which activate TAS2Rs already at low concentrations, exceeds the number of potent synthetic substances,8 one could speculate that the dominant trait affecting the evolution of the system is detection sensitivity. The number of human bitter taste receptors activated by natural or synthetic bitter compounds (cf. refs 8, 9, and 69) appears quite similar with 17 TAS2Rs being responsive to natural compounds and 20 receptors responding to synthetic compounds. Sixteen receptors were actually activated by both. This is also true for individual compound receptor combinations. Whereas the synthetic substance diphenidol with 15 cognate receptors activates the largest number of human TAS2Rs, the natural substance quinine is able to elicit responses from 9 receptors. Moreover, there are numerous examples for both natural and synthetic chemicals that activate several different TAS2Rs.8 Evidence is still missing to demonstrate if the number of cognate bitter receptors determines the perceived bitterness of a given compound. Because overall bitter chemicals stimulate their various cognate TAS2Rs with different potencies and efficacies, it is likely that some receptors contribute more to the perceived bitterness of a compound than others. Recent research started to address the question of whether the ability of certain bitter compounds to activate many bitter receptors is intrinsic to the substance or dependent on the individual bitter taste receptor repertoire of a biological species and whether specific chemical features identify broad-acting bitter substances compared to compounds with a limited spectrum of responding bitter taste receptors. It was shown that some substances such as the antibiotic chloramphenicol, which activates 9 human TAS2Rs,8,9 also activated all 3 chicken, all 2 turkey, 1 of 3 tested zebra finch, and 4 of 6 tested frog Tas2rs66 as well as 2 mouse TAS2Rs;69 similarly diphenidol, which acted most broadly on human TAS2Rs,8 activated chicken (3 of 3), turkey (2 of 2), zebra finch (2 of 3), frog (1 of 6),66 and mouse Tas2rs (6 of 34).69 According to in silico analyses of molecular properties of

Figure 5. Chemical structures and sources of bitter substances are highly diverse. The diversity of bitter compound structures ranges from small inorganic salts to complex organic substances. The compounds originate from biological to abiotic sources and processes related to food production.

and information about perceptual properties of chemicals.82 It appears reasonable to assume that the number of identified bitter substances will increase considerably with time and may easily exceed 1000. It is important to note that the term “bitter” for the taste of these substances cannot be simply extended to species other than humans. Although there is usually a good overlap between substances that represent aversive stimuli to other species and their bitter taste in humans, differences should be anticipated. These differences could be due to different bitter taste receptor gene repertoires shaped to meet the corresponding ecological niches of the species, as well as alternative routes leading to orosensorically mediated aversive reactions such as irritants activating TRP channels residing in the oral cavity83,84 or compounds eliciting a dry, tightened mouthfeel called astringency.85,86 Not all substances that taste bitter to humans have been matched with one of the 25 human TAS2Rs in vitro.8 One explanation for this unanticipated outcome could be technical issues preventing the deorphanization of the remaining four orphan human TAS2Rs that could possess the necessary recognition spectra to close this gap. Another possibility is the existence of TAS2R-independent bitter detection routes. Indeed, direct interaction of cellpermeable bitter compounds with intracellular signaling molecules87,88 as well as alternative receptors such as the nicotinic acetylcholine receptor, which has been identified in taste receptor cells of rodents,89 have been proposed. Bitter substances exert a wide range of pharmacological activities, which include, but are not limited to, acute toxic effects.90 One of the most infamous toxic bitter compounds is the alkaloid strychnine from the seeds of the Strychnos nuxvomica tree that acts as a glycin receptor antagonist leading91 to muscular convulsions. Less known, but with a similar mode of action, is the sesquiterpene lactone picrotoxinin from the seeds of the plant Anamirta cocculus, which inhibits GABA A receptors,92 again resulting in potentially deadly convulsions. Interestingly, both compounds occur in the corresponding plants mixed with structurally closely related substances called brucin and picrotin, respectively, which are nevertheless less potent bitter compounds7,93 demonstrating pronounced 2209


Perspective


interact with subsets of chemically diverse bitter agonists. An indication for agonists based on multiple distinct chemical scaffolds was recently provided for in silico predicted novel TAS2R14 agonists107 and could apply to other receptors as well. Of course, this considerably obscures the identification of individual pharmacophores. Most likely only some (if any at all) of the identified bitter activators of present day’s bitter taste receptors are identical to those that shaped the evolution of the receptors. Major vertebrate classes were already formed prior to the neophyticum/upper Cretaceous period when angiosperm plants, which have dominated our planet since then, started to conquer the earth. Clearly, the early development of nowadays bitter receptors was not driven by bitter substances originating from “modern” plants, but rather by toxic compounds from other sources. Also, climate and habitat changes that early humans faced when they started to migrate out of Africa obscure the bitter substance−receptor co-evolution because plants growing ∼2 million years ago in Africa dominantly shaped our TAS2R gene repertoire. Hence, it is anticipated that important contributions on the structures of relevant bitter substances may come from botanical and paleobotanical experts who join the field of bitter taste research. Finally, the relationship between bitterness and toxicity is less tight than frequently assumed.1 It would be highly relevant to investigate this question from an ecological point of view to see if bitterness is mostly indicating potential toxins or if it is also guiding seeking behavior for therapeutic substances in the case of illness49,50 and whether plants may synthesize not only toxins to defend against herbivores but also, as a kind of chemical mimicry,108 nontoxic substances. The occurrence of natural bitter receptor inhibitors raises the question of how abundant such molecules are in nature and if the existence of such modulatory compounds has influenced the evolution bitter taste receptor gene repertoires. It may well be that the expansion of bitter taste receptor genes was not dominantly influenced by the need to recognize more and more bitter substances, but rather to avoid as much as possible completely overlapping activities of activators and inhibitors with potentially fatal outcomes.100 In the future large screening campaigns to identify more natural bitter inhibitors may help to clarify this question.

broadly versus narrowly acting bitter substances, it is suggested that, among other descriptors, small and globular substances behave rather promiscuously, whereas large and flat molecules tend to be bitter taste receptor selective.98 Not all molecules that bind to TAS2Rs act as agonists; rather, some represent antagonists. The first receptor selective but rather broad-acting antagonist was discovered in a highthroughput screening devoted to discover small molecules able to block the bitter off-taste of the artificial sulfonyl amide sweeteners saccharin and acesulfame K.99 It was demonstrated that the compound 4-(2,2,3-trimethylcyclopentyl)butanoic acid, also known as GIV3727, potently inhibited the activation of the two dominant bitter receptors for saccharin’s and acesulfame K’s bitterness, TAS2R31 and TAS2R43, by a competitive mode of action. Soon thereafter, the first natural bitter inhibitors were identified.100 These compounds were strikingly similar to bona fide agonists of the receptor TAS2R46; however, they did not activate, but rather inhibited, the receptor. Because these substances, 3β-hydroxydihydrocostunolide and 3β-hydroxypelenolide, occur in the same plants that produce TAS2R46 activating sesquiterpene lactones, a previously unanticipated level of complexity for the bitterness of plants became evident. Moreover, all inhibitors, GIV3727 as well as the natural bitter blockers, surprisingly exhibited a bivalent feature by acting as bitter inhibitors on some TAS2Rs and as bitter agonists on others. After these initial reports, a growing number of bitter blockers were identified (see, e.g. refs 32, 101, and 102), indicating that such molecules may not be rare. Future Directions. There are many open questions concerning bitter substances that remain to be answered. One of these is the existence of common chemical (core) structures that identify bitter substances. This question was already asked, and partially answered, by Tancredi and colleagues many years before bitter taste receptor genes were identified.103 On the basis of previous models predicting that the common core structure of sweet molecules would consist of a hydrogen bond donor and acceptor site at a distance of about 3 Å,104,105 it was suggested that bitter compounds have a similar structure but with a reverse orientation.103 Whereas this model indeed explained why D- and L-enantiomers of some amino acids elicit a pronounced sweet or bitter taste, the finding that so many differently tuned TAS2Rs exist in humans argues for a more complex interaction pattern. For 2 of the 25 receptors, TAS2R16 and the TAS2R38, such common chemical structures, namely, the β-D-glucopyranose moiety and the isothiocyanate/thiourea moiety, respectively, were identified.5,10 However, other receptors seem to respond to a larger variety of chemicals. There are several possible explanations for the difficulties associated with the identification of common pharmacophores for TAS2Rs: First, recent evidence was provided that not only bitter agonists can be found in nature but also antagonists. Because the majority of studies so far relied on assays measuring receptor activation in vitro and not ligand binding, the identification of the chemical core structure required for binding to the receptors without leading to activation was usually not implemented. Recent publications using competitive approaches making use of agonists/ antagonist mixtures32,99−102,106,107 could close this gap because classical binding assays suffer from the rather low affinities of most bitter compound−receptor interactions and, as a consequence, no such data exist. Second, some bitter receptor binding sites may actually be composed of subsites, which

■

AUTHOR INFORMATION

Corresponding Author

*(M.B.) Fax: +49 33200 88 2384. Phone: +49 33200 88 2545. E-mail: [email protected]. ORCID

Maik Behrens: 0000-0003-2082-8860 Notes

The authors declare no competing financial interest.

■

REFERENCES

(1) Glendinning, J. I. Is the bitter rejection response always adaptive? Physiol. Behav. 1994, 56, 1217−1227. (2) Adler, E.; Hoon, M. A.; Mueller, K. L.; Chandrashekar, J.; Ryba, N. J.; Zuker, C. S. A novel family of mammalian taste receptors. Cell 2000, 100, 693−702. (3) Chandrashekar, J.; Mueller, K. L.; Hoon, M. A.; Adler, E.; Feng, L.; Guo, W.; Zuker, C. S.; Ryba, N. J. T2Rs function as bitter taste receptors. Cell 2000, 100, 703−711.

2210


Perspective

Journal of Agricultural and Food Chemistry (4) Matsunami, H.; Montmayeur, J. P.; Buck, L. B. A family of candidate taste receptors in human and mouse. Nature 2000, 404, 601−604. (5) Bufe, B.; Hofmann, T.; Krautwurst, D.; Raguse, J. D.; Meyerhof, W. The human TAS2R16 receptor mediates bitter taste in response to beta-glucopyranosides. Nat. Genet. 2002, 32, 397−401. (6) Kuhn, C.; Bufe, B.; Batram, C.; Meyerhof, W. Oligomerization of TAS2R bitter taste receptors. Chem. Senses 2010, 35, 395−406. (7) Behrens, M.; Brockhoff, A.; Kuhn, C.; Bufe, B.; Winnig, M.; Meyerhof, W. The human taste receptor hTAS2R14 responds to a variety of different bitter compounds. Biochem. Biophys. Res. Commun. 2004, 319, 479−485. (8) Meyerhof, W.; Batram, C.; Kuhn, C.; Brockhoff, A.; Chudoba, E.; Bufe, B.; Appendino, G.; Behrens, M. The molecular receptive ranges of human TAS2R bitter taste receptors. Chem. Senses 2010, 35, 157− 170. (9) Thalmann, S.; Behrens, M.; Meyerhof, W. Major haplotypes of the human bitter taste receptor TAS2R41 encode functional receptors for chloramphenicol. Biochem. Biophys. Res. Commun. 2013, 435, 267− 273. (10) Bufe, B.; Breslin, P. A.; Kuhn, C.; Reed, D. R.; Tharp, C. D.; Slack, J. P.; Kim, U. K.; Drayna, D.; Meyerhof, W. The molecular basis of individual differences in phenylthiocarbamide and propylthiouracil bitterness perception. Curr. Biol. 2005, 15, 322−327. (11) Kim, U.; Wooding, S.; Ricci, D.; Jorde, L. B.; Drayna, D. Worldwide haplotype diversity and coding sequence variation at human bitter taste receptor loci. Hum. Mutat. 2005, 26, 199−204. (12) Wooding, S.; Kim, U. K.; Bamshad, M. J.; Larsen, J.; Jorde, L. B.; Drayna, D. Natural selection and molecular evolution in PTC, a bittertaste receptor gene. Am. J. Hum. Genet. 2004, 74, 637−646. (13) Dotson, C. D.; Zhang, L.; Xu, H.; Shin, Y. K.; Vigues, S.; Ott, S. H.; Elson, A. E.; Choi, H. J.; Shaw, H.; Egan, J. M.; Mitchell, B. D.; Li, X.; Steinle, N. I.; Munger, S. D. Bitter taste receptors influence glucose homeostasis. PLoS One 2008, 3, e3974. (14) Kim, U. K.; Jorgenson, E.; Coon, H.; Leppert, M.; Risch, N.; Drayna, D. Positional cloning of the human quantitative trait locus underlying taste sensitivity to phenylthiocarbamide. Science 2003, 299, 1221−1225. (15) Pronin, A. N.; Xu, H.; Tang, H.; Zhang, L.; Li, Q.; Li, X. Specific alleles of bitter receptor genes influence human sensitivity to the bitterness of aloin and saccharin. Curr. Biol. 2007, 17, 1403−1408. (16) Roudnitzky, N.; Behrens, M.; Engel, A.; Kohl, S.; Thalmann, S.; Hubner, S.; Lossow, K.; Wooding, S. P.; Meyerhof, W. Receptor polymorphism and genomic structure interact to shape bitter taste perception. PLoS Genet. 2015, 11, e1005530. (17) Roudnitzky, N.; Bufe, B.; Thalmann, S.; Kuhn, C.; Gunn, H. C.; Xing, C.; Crider, B. P.; Behrens, M.; Meyerhof, W.; Wooding, S. P. Genomic, genetic and functional dissection of bitter taste responses to artificial sweeteners. Hum. Mol. Genet. 2011, 20, 3437−3449. (18) Roudnitzky, N.; Risso, D.; Drayna, D.; Behrens, M.; Meyerhof, W.; Wooding, S. P. Copy number variation in TAS2R bitter taste receptor genes: structure, origin, and population genetics. Chem. Senses 2016, 41, 649−659. (19) Soranzo, N.; Bufe, B.; Sabeti, P. C.; Wilson, J. F.; Weale, M. E.; Marguerie, R.; Meyerhof, W.; Goldstein, D. B. Positive selection on a high-sensitivity allele of the human bitter-taste receptor TAS2R16. Curr. Biol. 2005, 15, 1257−1265. (20) Sandell, M. A.; Breslin, P. A. Variability in a taste-receptor gene determines whether we taste toxins in food. Curr. Biol. 2006, 16, R792−R794. (21) Lee, R. J.; Xiong, G.; Kofonow, J. M.; Chen, B.; Lysenko, A.; Jiang, P.; Abraham, V.; Doghramji, L.; Adappa, N. D.; Palmer, J. N.; Kennedy, D. W.; Beauchamp, G. K.; Doulias, P. T.; Ischiropoulos, H.; Kreindler, J. L.; Reed, D. R.; Cohen, N. A. T2R38 taste receptor polymorphisms underlie susceptibility to upper respiratory infection. J. Clin. Invest. 2012, 122, 4145−4159. (22) Campbell, M. C.; Ranciaro, A.; Zinshteyn, D.; Rawlings-Goss, R.; Hirbo, J.; Thompson, S.; Woldemeskel, D.; Froment, A.; Rucker, J. B.; Omar, S. A.; Bodo, J. M.; Nyambo, T.; Belay, G.; Drayna, D.;

Breslin, P. A.; Tishkoff, S. A. Origin and differential selection of allelic variation at TAS2R16 associated with salicin bitter taste sensitivity in Africa. Mol. Biol. Evol. 2014, 31, 288−302. (23) Lee, R. J.; Cohen, N. A. Bitter and sweet taste receptors in the respiratory epithelium in health and disease. J. Mol. Med. (Heidelberg, Ger.) 2014, 92, 1235−1244. (24) Behrens, M.; Meyerhof, W. Bitter taste receptor research comes of age: from characterization to modulation of TAS2Rs. Semin. Cell Dev. Biol. 2013, 24, 215−221. (25) Di Pizio, A.; Levit, A.; Slutzki, M.; Behrens, M.; Karaman, R.; Niv, M. Y. Comparing Class A GPCRs to bitter taste receptors: structural motifs, ligand interactions and agonist-to-antagonist ratios. Methods Cell Biol. 2016, 132, 401−427. (26) Pydi, S. P.; Upadhyaya, J.; Singh, N.; Pal Bhullar, R.; Chelikani, P. Recent advances in structure and function studies on human bitter taste receptors. Curr. Protein Pept. Sci. 2012, 13, 501−508. (27) Brockhoff, A.; Behrens, M.; Niv, M. Y.; Meyerhof, W. Structural requirements of bitter taste receptor activation. Proc. Natl. Acad. Sci. U. S. A. 2010, 107, 11110−11115. (28) Sandal, M.; Behrens, M.; Brockhoff, A.; Musiani, F.; Giorgetti, A.; Carloni, P.; Meyerhof, W. Evidence for a transient additional ligand binding site in the TAS2R46 bitter taste receptor. J. Chem. Theory Comput. 2015, 11, 4439−4449. (29) Born, S.; Levit, A.; Niv, M. Y.; Meyerhof, W.; Behrens, M. The human bitter taste receptor TAS2R10 is tailored to accommodate numerous diverse ligands. J. Neurosci. 2013, 33, 201−213. (30) Sakurai, T.; Misaka, T.; Ishiguro, M.; Masuda, K.; Sugawara, T.; Ito, K.; Kobayashi, T.; Matsuo, S.; Ishimaru, Y.; Asakura, T.; Abe, K. Characterization of the beta-D-glucopyranoside binding site of the human bitter taste receptor hTAS2R16. J. Biol. Chem. 2010, 285, 28373−28378. (31) Marchiori, A.; Capece, L.; Giorgetti, A.; Gasparini, P.; Behrens, M.; Carloni, P.; Meyerhof, W. Coarse-grained/molecular mechanics of the TAS2R38 bitter taste receptor: experimentally-validated detailed structural prediction of agonist binding. PLoS One 2013, 8, e64675. (32) Pydi, S. P.; Sobotkiewicz, T.; Billakanti, R.; Bhullar, R. P.; Loewen, M. C.; Chelikani, P. Amino acid derivatives as bitter taste receptor (T2R) blockers. J. Biol. Chem. 2014, 289, 25054−25066. (33) Pronin, A. N.; Tang, H.; Connor, J.; Keung, W. Identification of ligands for two human bitter T2R receptors. Chem. Senses 2004, 29, 583−593. (34) Grus, W. E.; Zhang, J. Origin of the genetic components of the vomeronasal system in the common ancestor of all extant vertebrates. Mol. Biol. Evol. 2009, 26, 407−419. (35) Zhao, H.; Li, J.; Zhang, J. Molecular evidence for the loss of three basic tastes in penguins. Curr. Biol. 2015, 25, R141−142. (36) Feng, P.; Zheng, J.; Rossiter, S. J.; Wang, D.; Zhao, H. Massive losses of taste receptor genes in toothed and baleen whales. Genome Biol. Evol. 2014, 6, 1254−1265. (37) Jiang, P.; Josue, J.; Li, X.; Glaser, D.; Li, W.; Brand, J. G.; Margolskee, R. F.; Reed, D. R.; Beauchamp, G. K. Major taste loss in carnivorous mammals. Proc. Natl. Acad. Sci. U. S. A. 2012, 109, 4956− 4961. (38) Kishida, T.; Thewissen, J.; Hayakawa, T.; Imai, H.; Agata, K. Aquatic adaptation and the evolution of smell and taste in whales. Zoological Lett. 2015, 1, 9. (39) Liu, Z.; Liu, G.; Hailer, F.; Orozco-terWengel, P.; Tan, X.; Tian, J.; Yan, Z.; Zhang, B.; Li, M. Dietary specialization drives multiple independent losses and gains in the bitter taste gene repertoire of Laurasiatherian mammals. Front. Zool. 2016, 13, 28. (40) Zhu, K.; Zhou, X.; Xu, S.; Sun, D.; Ren, W.; Zhou, K.; Yang, G. The loss of taste genes in cetaceans. BMC Evol. Biol. 2014, 14, 218. (41) Shi, P.; Zhang, J.; Yang, H.; Zhang, Y. P. Adaptive diversification of bitter taste receptor genes in mammalian evolution. Mol. Biol. Evol. 2003, 20, 805−814. (42) Syed, A. S.; Korsching, S. I. Positive Darwinian selection in the singularly large taste receptor gene family of an ‘ancient’ fish, Latimeria chalumnae. BMC Genomics 2014, 15, 650. 2211


Perspective


(63) Li, F. Taste perception: from the tongue to the testis. Mol. Hum. Reprod. 2013, 19, 349−360. (64) Foster, S. R.; Blank, K.; See Hoe, L. E.; Behrens, M.; Meyerhof, W.; Peart, J. N.; Thomas, W. G. Bitter taste receptor agonists elicit Gprotein-dependent negative inotropy in the murine heart. FASEB J. 2014, 28, 4497−4508. (65) Foster, S. R.; Porrello, E. R.; Purdue, B.; Chan, H. W.; Voigt, A.; Frenzel, S.; Hannan, R. D.; Moritz, K. M.; Simmons, D. G.; Molenaar, P.; Roura, E.; Boehm, U.; Meyerhof, W.; Thomas, W. G. Expression, regulation and putative nutrient-sensing function of taste GPCRs in the heart. PLoS One 2013, 8, e64579. (66) Behrens, M.; Korsching, S. I.; Meyerhof, W. Tuning properties of avian and frog bitter taste receptors dynamically fit gene repertoire sizes. Mol. Biol. Evol. 2014, 31, 3216−3227. (67) Lei, W.; Ravoninjohary, A.; Li, X.; Margolskee, R. F.; Reed, D. R.; Beauchamp, G. K.; Jiang, P. Functional analyses of bitter taste receptors in domestic cats (Felis catus). PLoS One 2015, 10, e0139670. (68) Sandau, M. M.; Goodman, J. R.; Thomas, A.; Rucker, J. B.; Rawson, N. E. A functional comparison of the domestic cat bitter receptors Tas2r38 and Tas2r43 with their human orthologs. BMC Neurosci. 2015, 16, 33. (69) Lossow, K.; Hubner, S.; Roudnitzky, N.; Slack, J. P.; Pollastro, F.; Behrens, M.; Meyerhof, W. Comprehensive analysis of mouse bitter taste receptors reveals different molecular receptive ranges for orthologous receptors in mice and humans. J. Biol. Chem. 2016, 291, 15358−15377. (70) Chandrashekar, J.; Hoon, M. A.; Ryba, N. J.; Zuker, C. S. The receptors and cells for mammalian taste. Nature 2006, 444, 288−294. (71) Mueller, K. L.; Hoon, M. A.; Erlenbach, I.; Chandrashekar, J.; Zuker, C. S.; Ryba, N. J. The receptors and coding logic for bitter taste. Nature 2005, 434, 225−229. (72) Caicedo, A.; Roper, S. D. Taste receptor cells that discriminate between bitter stimuli. Science 2001, 291, 1557−1560. (73) Janssen, S.; Laermans, J.; Verhulst, P. J.; Thijs, T.; Tack, J.; Depoortere, I. Bitter taste receptors and alpha-gustducin regulate the secretion of ghrelin with functional effects on food intake and gastric emptying. Proc. Natl. Acad. Sci. U. S. A. 2011, 108, 2094−2099. (74) Jeon, T. I.; Zhu, B.; Larson, J. L.; Osborne, T. F. SREBP-2 regulates gut peptide secretion through intestinal bitter taste receptor signaling in mice. J. Clin. Invest. 2008, 118, 3693−3700. (75) Vegezzi, G.; Anselmi, L.; Huynh, J.; Barocelli, E.; Rozengurt, E.; Raybould, H.; Sternini, C. Diet-induced regulation of bitter taste receptor subtypes in the mouse gastrointestinal tract. PLoS One 2014, 9, e107732. (76) Prandi, S.; Bromke, M.; Hubner, S.; Voigt, A.; Boehm, U.; Meyerhof, W.; Behrens, M. A subset of mouse colonic goblet cells expresses the bitter taste receptor Tas2r131. PLoS One 2013, 8, e82820. (77) Singh, N.; Pydi, P.; Upadhyaya, J.; Chelikani, P. Structural basis of activation of bitter taste receptor T2R1 and comparison with class A GPCRs. J. Biol. Chem. 2011, 286, 36032−36041. (78) Lipchock, S. V.; Mennella, J. A.; Spielman, A. I.; Reed, D. R. Human bitter perception correlates with bitter receptor messenger RNA expression in taste cells. Am. J. Clin. Nutr. 2013, 98, 1136−1143. (79) Haggarty, P. Genetic and metabolic determinants of human epigenetic variation. Curr. Opin. Clin. Nutr. Metab. Care 2015, 18, 334−338. (80) Piatigorsky, J.; Wistow, G. J. Enzyme/crystallins: gene sharing as an evolutionary strategy. Cell 1989, 57, 197−199. (81) Meyerhof, W. Elucidation of mammalian bitter taste. Rev. Physiol. Biochem. Pharmacol. 2005, 154, 37−72. (82) Wiener, A.; Shudler, M.; Levit, A.; Niv, M. Y. BitterDB: a database of bitter compounds. Nucleic Acids Res. 2012, 40, D413−419. (83) Mancuso, G.; Borgonovo, G.; Scaglioni, L.; Bassoli, A. Phytochemicals from Ruta graveolens activate TAS2R bitter taste receptors and TRP channels involved in gustation and nociception. Molecules 2015, 20, 18907−18922. (84) Roper, S. D. TRPs in taste and chemesthesis. Handb. Exp. Pharmacol. 2014, 223, 827−871.

(43) Breslin, P. A. An evolutionary perspective on food and human taste. Curr. Biol. 2013, 23, R409−R418. (44) Drewnowski, A. The science and complexity of bitter taste. Nutr. Rev. 2001, 59, 163−169. (45) Roura, E.; Baldwin, M.; Klasing, K. The avian taste system: an update. In 23rd Annual Australian Poultry Science Symposium, Sydney, 2012; pp 97−104. (46) Hu, L. L.; Shi, P. Smallest bitter taste receptor (T2Rs) gene repertoire in carnivores. Zool. Res. 2013, 34, E75−E81. (47) Li, D.; Zhang, J. Diet shapes the evolution of the vertebrate bitter taste receptor gene repertoire. Mol. Biol. Evol. 2014, 31, 303− 309. (48) Freeland, W. J.; Janzen, D. H. Strategies in herbivory by mammals: the role of plant secondary compounds. Am. Nat. 1974, 108, 269−289. (49) Koshimizu, K.; Ohigashi, H.; Huffman, M. A. Use of Vernonia amygdalina by wild chimpanzee: possible roles of its bitter and related constituents. Physiol. Behav. 1994, 56, 1209−1216. (50) Villalba, J. J.; Miller, J.; Ungar, E. D.; Landau, S. Y.; Glendinning, J. Ruminant self-medication against gastrointestinal nematodes: evidence, mechanism, and origins. Parasite 2014, 21, 31. (51) Behrens, M.; Foerster, S.; Staehler, F.; Raguse, J. D.; Meyerhof, W. Gustatory expression pattern of the human TAS2R bitter receptor gene family reveals a heterogenous population of bitter responsive taste receptor cells. J. Neurosci. 2007, 27, 12630−12640. (52) Avau, B.; Depoortere, I. The bitter truth about bitter taste receptors: beyond sensing bitter in the oral cavity. Acta Physiol. 2016, 216, 407−420. (53) Behrens, M.; Prandi, S.; Meyerhof, W. Taste Receptor Gene Expression Outside the Gustatory System; Springer: Berlin, Germany, 2014; pp 1−34, DOI: 10.1007/7355_2014_79. (54) Ansoleaga, B.; Garcia-Esparcia, P.; Llorens, F.; Moreno, J.; Aso, E.; Ferrer, I. Dysregulation of brain olfactory and taste receptors in AD, PSP and CJD, and AD-related model. Neuroscience 2013, 248C, 369−382. (55) Dehkordi, O.; Rose, J. E.; Fatemi, M.; Allard, J. S.; Balan, K. V.; Young, J. K.; Fatima, S.; Millis, R. M.; Jayam-Trouth, A. Neuronal expression of bitter taste receptors and downstream signaling molecules in the rat brainstem. Brain Res. 2012, 1475, 1−10. (56) Garcia-Esparcia, P.; Schluter, A.; Carmona, M.; Moreno, J.; Ansoleaga, B.; Torrejon-Escribano, B.; Gustincich, S.; Pujol, A.; Ferrer, I. Functional genomics reveals dysregulation of cortical olfactory receptors in Parkinson disease: novel putative chemoreceptors in the human brain. J. Neuropathol. Exp. Neurol. 2013, 72, 524−539. (57) Singh, N.; Vrontakis, M.; Parkinson, F.; Chelikani, P. Functional bitter taste receptors are expressed in brain cells. Biochem. Biophys. Res. Commun. 2011, 406, 146−151. (58) Ekoff, M.; Choi, J. H.; James, A.; Dahlen, B.; Nilsson, G.; Dahlen, S. E. Bitter taste receptor (TAS2R) agonists inhibit IgEdependent mast cell activation. J. Allergy Clin. Immunol. 2014, 134, 475−478. (59) Malki, A.; Fiedler, J.; Fricke, K.; Ballweg, I.; Pfaffl, M. W.; Krautwurst, D. Class I odorant receptors, TAS1R and TAS2R taste receptors, are markers for subpopulations of circulating leukocytes. J. Leukocyte Biol. 2015, 97, 533−545. (60) Marcinek, P.; Geithe, C.; Krautwurst, D. Chemosensory G Protein-Coupled Receptors (GPCR) in Blood Leukocytes; Springer: Berlin, Germany, 2016; pp 1−23, DOI: 10.1007/7355_2016_101. (61) Maurer, S.; Wabnitz, G. H.; Kahle, N. A.; Stegmaier, S.; Prior, B.; Giese, T.; Gaida, M. M.; Samstag, Y.; Hansch, G. M. Tasting Pseudomonas aeruginosa biofilms: human neutrophils express the bitter receptor T2R38 as sensor for the quorum sensing molecule N-(3oxododecanoyl)-l-homoserine lactone. Front. Immunol. 2015, 6, 369. (62) Orsmark-Pietras, C.; James, A.; Konradsen, J. R.; Nordlund, B.; Soderhall, C.; Pulkkinen, V.; Pedroletti, C.; Daham, K.; Kupczyk, M.; Dahlen, B.; Kere, J.; Dahlen, S. E.; Hedlin, G.; Melen, E. Transcriptome analysis reveals upregulation of bitter taste receptors in severe asthmatics. Eur. Respir. J. 2013, 42, 65−78. 2212


Perspective

Journal of Agricultural and Food Chemistry (85) Fleming, E. E.; Ziegler, G. R.; Hayes, J. E. Salivary protein levels as a predictor of perceived astringency in model systems and solid foods. Physiol. Behav. 2016, 163, 56−63. (86) Schobel, N.; Radtke, D.; Kyereme, J.; Wollmann, N.; Cichy, A.; Obst, K.; Kallweit, K.; Kletke, O.; Minovi, A.; Dazert, S.; Wetzel, C. H.; Vogt-Eisele, A.; Gisselmann, G.; Ley, J. P.; Bartoshuk, L. M.; Spehr, J.; Hofmann, T.; Hatt, H. Astringency is a trigeminal sensation that involves the activation of G protein-coupled signaling by phenolic compounds. Chem. Senses 2014, 39, 471−487. (87) Gees, M.; Alpizar, Y. A.; Luyten, T.; Parys, J. B.; Nilius, B.; Bultynck, G.; Voets, T.; Talavera, K. Differential effects of bitter compounds on the taste transduction channels TRPM5 and IP3 receptor type 3. Chem. Senses 2014, 39, 295−311. (88) Peri, I.; Mamrud-Brains, H.; Rodin, S.; Krizhanovsky, V.; Shai, Y.; Nir, S.; Naim, M. Rapid entry of bitter and sweet tastants into liposomes and taste cells: implications for signal transduction. Am. J. Physiol. Cell Physiol. 2000, 278, C17−C25. (89) Ren, Z. J.; Mummalaneni, S.; Qian, J.; Baumgarten, C. M.; DeSimone, J. A.; Lyall, V. Nicotinic acetylcholine receptor (nAChR) dependent chorda tympani taste nerve responses to nicotine, ethanol and acetylcholine. PLoS One 2015, 10, e0127936. (90) Barratt-Fornell, A.; Drewnowski, A. The taste of health: nature’s bitter gifts. Nutr. Today 2002, 37, 144−150. (91) Young, A. B.; Snyder, S. H. Strychnine binding associated with glycine receptors of the central nervous system. Proc. Natl. Acad. Sci. U. S. A. 1973, 70, 2832−2836. (92) Perret, P.; Sarda, X.; Wolff, M.; Wu, T. T.; Bushey, D.; Goeldner, M. Interaction of non-competitive blockers within the gamma-aminobutyric acid type A chloride channel using chemically reactive probes as chemical sensors for cysteine mutants. J. Biol. Chem. 1999, 274, 25350−25354. (93) Brockhoff, A.; Behrens, M.; Massarotti, A.; Appendino, G.; Meyerhof, W. Broad tuning of the human bitter taste receptor hTAS2R46 to various sesquiterpene lactones, clerodane and labdane diterpenoids, strychnine, and denatonium. J. Agric. Food Chem. 2007, 55, 6236−6243. (94) Deiml, T.; Haseneder, R.; Zieglgansberger, W.; Rammes, G.; Eisensamer, B.; Rupprecht, R.; Hapfelmeier, G. Alpha-thujone reduces 5-HT3 receptor activity by an effect on the agonist-reduced desensitization. Neuropharmacology 2004, 46, 192−201. (95) Miller, P. S.; Smart, T. G. Binding, activation and modulation of Cys-loop receptors. Trends Pharmacol. Sci. 2010, 31, 161−174. (96) Hien, T. T.; White, N. J. Qinghaosu. Lancet 1993, 341, 603− 608. (97) Vane, J. R. The fight against rheumatism: from willow bark to COX-1 sparing drugs. J. Physiol. Pharmacol. 2000, 51, 573−586. (98) Di Pizio, A.; Niv, M. Y. Promiscuity and selectivity of bitter molecules and their receptors. Bioorg. Med. Chem. 2015, 23, 4082− 4091. (99) Slack, J. P.; Brockhoff, A.; Batram, C.; Menzel, S.; Sonnabend, C.; Born, S.; Galindo, M. M.; Kohl, S.; Thalmann, S.; OstopoviciHalip, L.; Simons, C. T.; Ungureanu, I.; Duineveld, K.; Bologa, C. G.; Behrens, M.; Furrer, S.; Oprea, T. I.; Meyerhof, W. Modulation of bitter taste perception by a small molecule hTAS2R antagonist. Curr. Biol. 2010, 20, 1104−1109. (100) Brockhoff, A.; Behrens, M.; Roudnitzky, N.; Appendino, G.; Avonto, C.; Meyerhof, W. Receptor agonism and antagonism of dietary bitter compounds. J. Neurosci. 2011, 31, 14775−14782. (101) Greene, T. A.; Alarcon, S.; Thomas, A.; Berdougo, E.; Doranz, B. J.; Breslin, P. A.; Rucker, J. B. Probenecid inhibits the human bitter taste receptor TAS2R16 and suppresses bitter perception of salicin. PLoS One 2011, 6, e20123. (102) Roland, W. S.; Gouka, R. J.; Gruppen, H.; Driesse, M.; van Buren, L.; Smit, G.; Vincken, J. P. 6-Methoxyflavanones as bitter taste receptor blockers for hTAS2R39. PLoS One 2014, 9, e94451. (103) Tancredi, T.; Lelj, F.; Temussi, P. A. Three-dimensional mapping of the bitter taste receptor site. Chem. Senses 1979, 4, 259− 265.

(104) Shallenberger, R. S.; Acree, T. E. Molecular theory of sweet taste. Nature 1967, 216, 480−482. (105) Shallenberger, R. S.; Acree, T. E.; Lee, C. Y. Sweet taste of Dand L-sugars and amino-acids and the steric nature of their chemoreceptor site. Nature 1969, 221, 555−556. (106) Karaman, R.; Nowak, S.; Di Pizio, A.; Kitaneh, H.; Abu-Jaish, A.; Meyerhof, W.; Niv, M. Y.; Behrens, M. Probing the binding pocket of the broadly tuned human bitter taste receptor TAS2R14 by chemical modification of cognate agonists. Chem. Biol. Drug Des. 2016, 88, 66−75. (107) Levit, A.; Nowak, S.; Peters, M.; Wiener, A.; Meyerhof, W.; Behrens, M.; Niv, M. Y. The bitter pill: clinical drugs that activate the human bitter taste receptor TAS2R14. FASEB J. 2014, 28, 1181−1197. (108) Dettner, K.; Liepert, C. Chemical mimicry and camouflage. Annu. Rev. Entomol. 1994, 39, 129−154.

2213


Vertebrate Bitter Taste Receptors: Keys for Survival ... - ACS Publications

Recommend Documents